Vaccine Contract Manufacturing Market - Global Industry Analysis

Vaccine Contract Manufacturing Market - By Workflow (Downstream and Upstream), By Vaccine Type (Attenuated, Subunit, DNA, Inactivated, and Toxoid), By Application (Human and Veterinary), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026

Published Date: 11-May-2021 Category: Medical Device Report Format : PDF Pages: 130 Report Code: ZMR-6236 Status : Published

The global Vaccine Contract Manufacturing market accrued earnings worth approximately 1.3(USD Billion) in 2019 and is predicted to gain revenue of about 5.7(USD Billion) by 2026, is set to record a CAGR of nearly 12.5% over the period from 2020 to 2026.

Description

The global Vaccine Contract Manufacturing market accrued earnings worth approximately 1.3(USD Billion) in 2019 and is predicted to gain revenue of about 5.7(USD Billion) by 2026, is set to record a CAGR of nearly 12.5% over the period from 2020 to 2026. The report offers assessment and analysis of the Vaccine Contract Manufacturing market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2017 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion).

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Vaccine Contract Manufacturing Market: Overview

Vaccine manufacturing sector is one among the challenging ones with the basic manufacturing steps being the most difficult to get executed in a safe & proficient manner. With thriving vaccine sector, both vaccine manufacturing industry as well as vaccine contract manufacturing market is likely to thrive over the coming decade. According to NCBI, overall vaccine sales in 2013 were over USD 24 billion and are slated to increase noticeably in the upcoming years. This will pave a way for exponential expansion of vaccine industry as well as vaccine contract manufacturing business over the years to come.  

Global Vaccine Contract Manufacturing Market

Vaccine Contract Manufacturing Market: Growth Factors

As per NCBI, presence of giant vaccine manufacturing firms based in the U.S. and Europe as well as new entrants evolving in the developing countries, the market for vaccine contract manufacturing is set to expand leaps & bounds in the years ahead. In addition to this, the need for reducing spread of COVID across the globe has forced governments to focus on manufacturing vaccines. This has led to massive growth of vaccine manufacturing business along with boosting vaccine contract manufacturing industry over 2020-2026.

Furthermore, large-scale demand for vaccines in emerging countries as well as under-developed countries will enlarge the scope of vaccine contract manufacturing industry over the assessment timeframe. Large-scale funding on research activities concerning vaccine production and need for maintaining the demand-supply equilibrium has influenced vaccine contract manufacturing market penetration. Furthermore, giant firms are entering into partnership with regional firms form expanding their customer base across the globe, thereby further impacting the expansion of the market. Apart from this, introduction of new products to the existing product line witnessed in the developed countries is likely to lead to expansion of vaccine contract manufacturing activities in the emerging economies, thereby inflating market size in these countries over the assessment timeline. However, with giant pharma firms across the globe adopting the strategy of producing vaccines in-house, the growth of vaccine contract manufacturing industry may witness a rapid decline & market revenue may be hit severely by the execution of this strategy in the years to come.

Regional Landscape

North American Market Share To Increase Sizably Over Forecast Period

The expansion of vaccine contract manufacturing market in North America over the assessment timespan is due to large-scale presence of bio-pharma firms in the U.S. In addition to this, legislations supporting the vaccine contract manufacturing activities in the sub-continent will add substantially to the GDP of the region due to surge in the vaccine contract manufacturing business, thereby providing impetus to the vaccine contract manufacturing industry in North America. Apart from this, a prominent increment in the contract research firms aided by both the government as well as funding from private sector will culminate in steep escalation of the market size in the sub-continent over 2020-2026.

Competitive Landscape

Key players profiled in the report include Goodwin Biotechnology, Inc., Minneapolis Medical Research Foundation (MMRF), Soligenix Inc., FUJIFILM Diosynth Biotechnologies, Thomas Jefferson University, Bavarian Nordic A/S, Emergent BioSolutions, BioMark, and Catalent Biologics.

The global Vaccine Contract Manufacturing Market is segmented as follows:

By Vaccine Type

  • Attenuated
  • Subunit
  • DNA
  • Inactivated
  • Toxoid

By Workflow

  • Downstream
  • Upstream

By Application

  • Human
  • Veterinary

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Type
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Vaccine Contract Manufacturing Market, 2016–2026(USD Billion)
    • 2.2. Vaccine Contract Manufacturing Market: Snapshot
  • Chapter 3. Global Vaccine Contract Manufacturing Market– Vaccine Type Analysis
    • 3.1. Vaccine Contract Manufacturing Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Launching of new products to the existing product line witnessed in the developed countries is likely to lead to surge in vaccine contract manufacturing activities across the emerging economies, thereby enhancing market size in these countries over the assessment timeframe.
      • 3.2.2. Need for reducing spread of COVID across the globe has forced governments to focus on manufacturing vaccines. This has led to humungous expansion of vaccine manufacturing business along with boosting vaccine contract manufacturing industry over estimated timeline.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Vaccine Type
      • 3.4.2. Market attractiveness analysis By Workflow
      • 3.4.3. Market attractiveness analysis By Application
  • Chapter 4. Global Vaccine Contract Manufacturing Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Vaccine Contract Manufacturing Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Vaccine Contract Manufacturing Market– Vaccine Type Analysis
    • 5.1. Global Vaccine Contract Manufacturing Market overview: By Vaccine Type
      • 5.1.1. Global Vaccine Contract Manufacturing Market share, By Vaccine Type , 2019 and 2026
    • 5.2. Attenuated
      • 5.2.1. Global Vaccine Contract Manufacturing Market by Attenuated, 2016–2026(USD Billion)
    • 5.3. Subunit
      • 5.3.1. Global Vaccine Contract Manufacturing Market by Subunit, 2016–2026(USD Billion)
    • 5.4. DNA
      • 5.4.1. Global Vaccine Contract Manufacturing Market by DNA, 2016–2026(USD Billion)
    • 5.5. Inactivated
      • 5.5.1. Global Vaccine Contract Manufacturing Market by Inactivated, 2016–2026(USD Billion)
    • 5.6. Toxoid
      • 5.6.1. Global Vaccine Contract Manufacturing Market by Toxoid, 2016–2026(USD Billion)
  • Chapter 6. Global Vaccine Contract Manufacturing Market– Workflow Analysis
    • 6.1. Global Vaccine Contract Manufacturing Market overview: By Workflow
      • 6.1.1. Global Vaccine Contract Manufacturing Market share, By Workflow, 2019 and 2026
    • 6.2. Downstream
      • 6.2.1. Global Vaccine Contract Manufacturing Market by Downstream, 2016–2026(USD Billion)
    • 6.3. Upstream
      • 6.3.1. Global Vaccine Contract Manufacturing Market by Upstream, 2016–2026(USD Billion)
  • Chapter 7. Global Vaccine Contract Manufacturing Market– Application Analysis
    • 7.1. Global Vaccine Contract Manufacturing Market overview: By Application
      • 7.1.1. Global Vaccine Contract Manufacturing Market share, By Application, 2019 and 2026
    • 7.2. Human
      • 7.2.1. Global Vaccine Contract Manufacturing Market by Human, 2016–2026(USD Billion)
    • 7.3. Veterinary
      • 7.3.1. Global Vaccine Contract Manufacturing Market by Veterinary, 2016–2026(USD Billion)
  • Chapter 8. Company Profiles
    • 8.1. Goodwin Biotechnulogy, Inc.
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product Portfolio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Minneapulis Medical Research Foundation (MMRF)
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product Portfolio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. Suligenix Inc.
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product Portfolio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Development
    • 8.4. FUJIFILM Diosynth Biotechnulogies
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product Portfolio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Development
    • 8.5. Thomas Jefferson University
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product Portfolio
      • 8.5.4. Business Strategy
      • 8.5.5. Recent Development
    • 8.6. Bavarian Nordic A/S
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product Portfolio
      • 8.6.4. Business Strategy
      • 8.6.5. Recent Development
    • 8.7. Emergent BioSulutions
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Product Portfolio
      • 8.7.4. Business Strategy
      • 8.7.5. Recent Development
    • 8.8. BioMark
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Product Portfolio
      • 8.8.4. Business Strategy
      • 8.8.5. Recent Development
    • 8.9. Catalent Biulogics
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Product Portfolio
      • 8.9.4. Business Strategy
      • 8.9.5. Recent Development

List of Figures

1. Market research Type
2. Market research methodology
3. Global Vaccine Contract Manufacturing   Market, 2016–2026(USD Billion)
4. Porter’s Five Forces Analysis
5. Global Vaccine Contract Manufacturing   Marketattractiveness, By Vaccine Type
6. Global Vaccine Contract Manufacturing   Marketattractiveness, By Workflow
7. Global Vaccine Contract Manufacturing   Marketattractiveness, By Application
8. Global Vaccine Contract Manufacturing   Marketshare by Vaccine Type ,2019 and 2026 (USD Billion)
9. Global Vaccine Contract Manufacturing   Marketby Attenuated, 2016–2026(USD Billion)
10. Global Vaccine Contract Manufacturing   Marketby Subunit, 2016–2026(USD Billion)
11. Global Vaccine Contract Manufacturing   Marketby DNA, 2016–2026(USD Billion)
12. Global Vaccine Contract Manufacturing   Marketby , Inactivated, 2016–2026(USD Billion)
13. Global Vaccine Contract Manufacturing   Marketby Toxoid, 2016–2026(USD Billion)
14. Global Vaccine Contract Manufacturing   Marketshare by Workflow ,2019 and 2026 (USD Billion)
15. Global Vaccine Contract Manufacturing   Marketby Downstream, 2016–2026(USD Billion)
16. Global Vaccine Contract Manufacturing   Marketby Upstream, 2016–2026(USD Billion)
17. Global Vaccine Contract Manufacturing   Marketshare by Application ,2019 and 2026 (USD Billion)
18. Global Vaccine Contract Manufacturing   Marketby Human, 2016–2026(USD Billion)
19. Global Vaccine Contract Manufacturing   Marketby Veterinary, 2016–2026(USD Billion)
20. Global Vaccine Contract Manufacturing   Marketshare, by Region, 2019 and 2026
21. North America Vaccine Contract Manufacturing   Market, 2016–2026(USD Billion)
22. Europe Vaccine Contract Manufacturing   Market, 2016–2026(USD Billion)
23. Asia Pacific Vaccine Contract Manufacturing   Market, 2016–2026(USD Billion)
24. Latin America Vaccine Contract Manufacturing   Market, 2016–2026(USD Billion)
25. The Middle East and Africa Vaccine Contract Manufacturing   Market, 2016–2026(USD Billion)


List of Tables

1. Global Vaccine Contract Manufacturing   Market: snapshot
2. Drivers of the Vaccine Contract Manufacturing   Market: impact analysis
3. North America Vaccine Contract Manufacturing   Market revenue, By Vaccine Type  ,2016–2026(USD Billion)
4. North America Vaccine Contract Manufacturing   Market revenue, By Workflow  ,2016–2026(USD Billion)
5. North America Vaccine Contract Manufacturing   Market revenue, By Application  ,2016–2026(USD Billion)
6. The U.S. Vaccine Contract Manufacturing   Market revenue, By Vaccine Type  ,2016–2026(USD Billion)
7. The U.S. Vaccine Contract Manufacturing   Market revenue, By Workflow  ,2016–2026(USD Billion)
8. The U.S. Vaccine Contract Manufacturing   Market revenue, By Application  ,2016–2026(USD Billion)
9. Rest of North America Vaccine Contract Manufacturing   Market revenue, By Vaccine Type  ,2016–2026(USD Billion)
10. Rest of North America Vaccine Contract Manufacturing   Market revenue, By Workflow  ,2016–2026(USD Billion)
11. Rest of North America Vaccine Contract Manufacturing   Market revenue, By Application  ,2016–2026(USD Billion)
12. Europe Vaccine Contract Manufacturing   Market revenue, By Vaccine Type  ,2016–2026(USD Billion)
13. Europe Vaccine Contract Manufacturing   Market revenue, By Workflow  ,2016–2026(USD Billion)
14. Europe Vaccine Contract Manufacturing   Market revenue, By Application  ,2016–2026(USD Billion)
15. UK Vaccine Contract Manufacturing   Market revenue, By Vaccine Type  ,2016–2026(USD Billion)
16. UK Vaccine Contract Manufacturing   Market revenue, By Workflow  ,2016–2026(USD Billion)
17. UK Vaccine Contract Manufacturing   Market revenue, By Application  ,2016–2026(USD Billion)
18. France Vaccine Contract Manufacturing   Market revenue, By Vaccine Type  ,2016–2026(USD Billion)
19. France Vaccine Contract Manufacturing   Market revenue, By Workflow  ,2016–2026(USD Billion)
20. France Vaccine Contract Manufacturing   Market revenue, By Application  ,2016–2026(USD Billion)
21. Germany Vaccine Contract Manufacturing   Market revenue, By Vaccine Type  ,2016–2026(USD Billion)
22. Germany Vaccine Contract Manufacturing   Market revenue, By Workflow  ,2016–2026(USD Billion)
23. Germany Vaccine Contract Manufacturing   Market revenue, By Application  ,2016–2026(USD Billion)
24. Rest of Europe Vaccine Contract Manufacturing   Market revenue, By Vaccine Type  ,2016–2026(USD Billion)
25. Rest of Europe Vaccine Contract Manufacturing   Market revenue, By Workflow  ,2016–2026(USD Billion)
26. Rest of Europe Vaccine Contract Manufacturing   Market revenue, By Application  ,2016–2026(USD Billion)
27. Asia Pacific Vaccine Contract Manufacturing   Market revenue, By Vaccine Type  ,2016–2026(USD Billion)
28. Asia Pacific Vaccine Contract Manufacturing   Market revenue, By Workflow  ,2016–2026(USD Billion)
29. Asia Pacific  Vaccine Contract Manufacturing   Market revenue, By Application  ,2016–2026(USD Billion)
30. China Vaccine Contract Manufacturing   Market revenue, By Vaccine Type  ,2016–2026(USD Billion)
31. China Vaccine Contract Manufacturing   Market revenue, By Workflow  ,2016–2026(USD Billion)
32. China Vaccine Contract Manufacturing   Market revenue, By Application  ,2016–2026(USD Billion)
33. Japan Vaccine Contract Manufacturing   Market revenue, By Vaccine Type  ,2016–2026(USD Billion)
34. Japan Vaccine Contract Manufacturing   Market revenue, By Workflow  ,2016–2026(USD Billion)
35. India Vaccine Contract Manufacturing   Market revenue, By Vaccine Type  ,2016–2026(USD Billion)
36. India Vaccine Contract Manufacturing   Market revenue, By Workflow  ,2016–2026(USD Billion)
37. India Vaccine Contract Manufacturing   Market revenue, By Application  ,2016–2026(USD Billion)
38. Rest of Asia Pacific Vaccine Contract Manufacturing   Market revenue, By Vaccine Type  ,2016–2026(USD Billion)
39. Rest of Asia Pacific Vaccine Contract Manufacturing   Market revenue, By Workflow  ,2016–2026(USD Billion)
40. Rest of Asia Pacific Vaccine Contract Manufacturing   Market revenue, By Application  ,2016–2026(USD Billion)
41. Latin America Vaccine Contract Manufacturing   Market revenue, By Vaccine Type  ,2016–2026(USD Billion)
42. Latin America Vaccine Contract Manufacturing   Market revenue, By Workflow  ,2016–2026(USD Billion)
43. Latin  America Vaccine Contract Manufacturing   Market revenue, By Application  ,2016–2026(USD Billion)
44. Brazil Vaccine Contract Manufacturing   Market revenue, By Vaccine Type  ,2016–2026(USD Billion)
45. Brazil Vaccine Contract Manufacturing   Market revenue, By Workflow  ,2016–2026(USD Billion)
46. Brazil Vaccine Contract Manufacturing   Market revenue, By Application  ,2016–2026(USD Billion)
47. Rest of Latin America Vaccine Contract Manufacturing   Market revenue, By Vaccine Type  ,2016–2026(USD Billion)
48. Rest of Latin America Vaccine Contract Manufacturing   Market revenue, By Workflow  ,2016–2026(USD Billion)
49. Rest of Latin  America Vaccine Contract Manufacturing   Market revenue, By Application  ,2016–2026(USD Billion)
50. The Middle East and Africa Vaccine Contract Manufacturing   Market revenue, By Vaccine Type  ,2016–2026(USD Billion)
51. The Middle East and Africa Vaccine Contract Manufacturing   Market revenue, By Workflow  ,2016–2026(USD Billion)
52. The Middle East and Africa Vaccine Contract Manufacturing   Market revenue, By Application  ,2016–2026(USD Billion)
53. Saudi Arabia Vaccine Contract Manufacturing   Market revenue, By Vaccine Type  ,2016–2026(USD Billion)
54. Saudi Arabia Vaccine Contract Manufacturing   Market revenue, By Workflow  ,2016–2026(USD Billion)
55. Saudi  Arabia Vaccine Contract Manufacturing   Market revenue, By Application  ,2016–2026(USD Billion)
56. South Africa Vaccine Contract Manufacturing   Market revenue, By Vaccine Type  ,2016–2026(USD Billion)
57. South Africa Vaccine Contract Manufacturing   Market revenue, By Workflow  ,2016–2026(USD Billion)
58. South Africa Vaccine Contract Manufacturing   Market revenue, By Application  ,2016–2026(USD Billion)
59. Rest of the Middle East & Africa Vaccine Contract Manufacturing   Market revenue, By Vaccine Type  ,2016–2026(USD Billion)
60. Rest of the Middle East & Africa Vaccine Contract Manufacturing   Market revenue, By Workflow  ,2016–2026(USD Billion)
61. Rest of the Middle East & Africa Vaccine Contract Manufacturing   Market revenue, By Application  ,2016–2026(USD Billion)

 
 

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

As per NCBI, presence of giant vaccine manufacturing firms based in the U.S. and Europe as well as new entrants evolving in the developing countries, the market for vaccine contract manufacturing is set to expand leaps & bounds in the years ahead. In addition to this, the need for reducing spread of COVID across the globe has forced governments to focus on manufacturing vaccines. This has led to massive growth of vaccine manufacturing business along with boosting vaccine contract manufacturing industry over 2020-2026.

Furthermore, large-scale demand for vaccines in emerging countries as well as under-developed countries will enlarge the scope of vaccine contract manufacturing industry over the assessment timeframe. Large-scale funding on research activities concerning vaccine production and need for maintaining the demand-supply equilibrium has influenced vaccine contract manufacturing market penetration. Furthermore, giant firms are entering into partnership with regional firms form expanding their customer base across the globe, thereby further impacting the expansion of the market.

According to Zion market research report, the global Vaccine Contract Manufacturing market accrued earnings worth approximately 1.3(USD Billion) in 2019 and is predicted to gain revenue of about 5.7(USD Billion) by 2026, is set to record a CAGR of nearly 12.5% over the period from 2020 to 2026.

North America will contribute lucratively towards the global market size over the estimated timeline. The regional market surge is due to large-scale presence of bio-pharma firms in the U.S. In addition to this, legislations supporting the vaccine contract manufacturing activities in the sub-continent will add substantially to the GDP of the region due to surge in the vaccine contract manufacturing business, thereby providing impetus to the vaccine contract manufacturing industry in North America. Apart from this, a prominent increment in the contract research firms aided by both the government as well as funding from private sector will culminate in steep escalation of the market size in the sub-continent over 2020-2026.

The key market participants include Goodwin Biotechnology, Inc., Minneapolis Medical Research Foundation (MMRF), Soligenix Inc., FUJIFILM Diosynth Biotechnologies, Thomas Jefferson University, Bavarian Nordic A/S, Emergent BioSolutions, BioMark, and Catalent Biologics.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed